According to a new report, published by KBV research, The Global Neuromonitoring Devices Market size is expected to reach $8.2 billion by 2028, rising at a market growth of 7.3% CAGR during the forecast period.
The EEG market is showcasing a CAGR of 6% during (2022 - 2028). A recording of brain activity is called an electroencephalogram (EEG). Small sensors are affixed to the scalp during this painless examination to collect the electrical signals generated by the brain. These impulses are recorded by a machine and examined by a clinician. A highly skilled professional known as a clinical neurophysiologist often performs the EEG technique during a brief hospital visit.
The North America market dominated the Global Neuromonitoring Devices Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3.05 billion by 2028. The Europe market is estimated to witness a CAGR of 6.9% during (2022 - 2028). Additionally, The Asia Pacific market would experience a CAGR of 7.9% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/neuromonitoring-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.
By Product
By Geography
Companies Profiled
Unique Offerings 
